Cargando…

Validated automatic speech biomarkers in primary progressive aphasia

OBJECTIVE: To automatically extract and quantify specific disease biomarkers of prosody from the acoustic properties of speech in patients with primary progressive aphasia. METHODS: We analyzed speech samples from 59 progressive aphasic patients (non‐fluent/agrammatic = 15, semantic = 21, logopenic ...

Descripción completa

Detalles Bibliográficos
Autores principales: Nevler, Naomi, Ash, Sharon, Irwin, David J, Liberman, Mark, Grossman, Murray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331511/
https://www.ncbi.nlm.nih.gov/pubmed/30656179
http://dx.doi.org/10.1002/acn3.653
_version_ 1783387147728846848
author Nevler, Naomi
Ash, Sharon
Irwin, David J
Liberman, Mark
Grossman, Murray
author_facet Nevler, Naomi
Ash, Sharon
Irwin, David J
Liberman, Mark
Grossman, Murray
author_sort Nevler, Naomi
collection PubMed
description OBJECTIVE: To automatically extract and quantify specific disease biomarkers of prosody from the acoustic properties of speech in patients with primary progressive aphasia. METHODS: We analyzed speech samples from 59 progressive aphasic patients (non‐fluent/agrammatic = 15, semantic = 21, logopenic = 23; ages 50–85 years) and 31 matched healthy controls (ages 54–89 years). Using a novel, automated speech analysis protocol, we extracted acoustic measurements of prosody, including fundamental frequency and speech and silent pause durations, and compared these between groups. We then examined their relationships with clinical tests, gray matter atrophy, and cerebrospinal fluid analytes. RESULTS: We found a narrowed range of fundamental frequency in patients with non‐fluent/agrammatic variant aphasia (mean 3.86 ± 1.15 semitones) compared with healthy controls (6.06 ± 1.95 semitones; P < 0.001) and patients with semantic variant aphasia (6.12 ± 1.77 semitones; P = 0.001). Mean pause rate was significantly increased in the non‐fluent/agrammatic group (mean 61.4 ± 20.8 pauses per minute) and the logopenic group (58.7 ± 16.4 pauses per minute) compared to controls. In an exploratory analysis, narrowed fundamental frequency range was associated with atrophy in the left inferior frontal cortex. Cerebrospinal level of phosphorylated tau was associated with an acoustic classifier combining fundamental frequency range and pause rate (r = 0.58, P = 0.007). Receiver operating characteristic analysis with this combined classifier distinguished non‐fluent/agrammatic speakers from healthy controls (AUC = 0.94) and from semantic variant patients (AUC = 0.86). INTERPRETATION: Restricted fundamental frequency range and increased pause rate are characteristic markers of speech in non‐fluent/agrammatic primary progressive aphasia. These can be extracted with automated speech analysis and are associated with left inferior frontal atrophy and cerebrospinal phosphorylated tau level.
format Online
Article
Text
id pubmed-6331511
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63315112019-01-17 Validated automatic speech biomarkers in primary progressive aphasia Nevler, Naomi Ash, Sharon Irwin, David J Liberman, Mark Grossman, Murray Ann Clin Transl Neurol Research Articles OBJECTIVE: To automatically extract and quantify specific disease biomarkers of prosody from the acoustic properties of speech in patients with primary progressive aphasia. METHODS: We analyzed speech samples from 59 progressive aphasic patients (non‐fluent/agrammatic = 15, semantic = 21, logopenic = 23; ages 50–85 years) and 31 matched healthy controls (ages 54–89 years). Using a novel, automated speech analysis protocol, we extracted acoustic measurements of prosody, including fundamental frequency and speech and silent pause durations, and compared these between groups. We then examined their relationships with clinical tests, gray matter atrophy, and cerebrospinal fluid analytes. RESULTS: We found a narrowed range of fundamental frequency in patients with non‐fluent/agrammatic variant aphasia (mean 3.86 ± 1.15 semitones) compared with healthy controls (6.06 ± 1.95 semitones; P < 0.001) and patients with semantic variant aphasia (6.12 ± 1.77 semitones; P = 0.001). Mean pause rate was significantly increased in the non‐fluent/agrammatic group (mean 61.4 ± 20.8 pauses per minute) and the logopenic group (58.7 ± 16.4 pauses per minute) compared to controls. In an exploratory analysis, narrowed fundamental frequency range was associated with atrophy in the left inferior frontal cortex. Cerebrospinal level of phosphorylated tau was associated with an acoustic classifier combining fundamental frequency range and pause rate (r = 0.58, P = 0.007). Receiver operating characteristic analysis with this combined classifier distinguished non‐fluent/agrammatic speakers from healthy controls (AUC = 0.94) and from semantic variant patients (AUC = 0.86). INTERPRETATION: Restricted fundamental frequency range and increased pause rate are characteristic markers of speech in non‐fluent/agrammatic primary progressive aphasia. These can be extracted with automated speech analysis and are associated with left inferior frontal atrophy and cerebrospinal phosphorylated tau level. John Wiley and Sons Inc. 2018-11-24 /pmc/articles/PMC6331511/ /pubmed/30656179 http://dx.doi.org/10.1002/acn3.653 Text en © 2018 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Nevler, Naomi
Ash, Sharon
Irwin, David J
Liberman, Mark
Grossman, Murray
Validated automatic speech biomarkers in primary progressive aphasia
title Validated automatic speech biomarkers in primary progressive aphasia
title_full Validated automatic speech biomarkers in primary progressive aphasia
title_fullStr Validated automatic speech biomarkers in primary progressive aphasia
title_full_unstemmed Validated automatic speech biomarkers in primary progressive aphasia
title_short Validated automatic speech biomarkers in primary progressive aphasia
title_sort validated automatic speech biomarkers in primary progressive aphasia
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331511/
https://www.ncbi.nlm.nih.gov/pubmed/30656179
http://dx.doi.org/10.1002/acn3.653
work_keys_str_mv AT nevlernaomi validatedautomaticspeechbiomarkersinprimaryprogressiveaphasia
AT ashsharon validatedautomaticspeechbiomarkersinprimaryprogressiveaphasia
AT irwindavidj validatedautomaticspeechbiomarkersinprimaryprogressiveaphasia
AT libermanmark validatedautomaticspeechbiomarkersinprimaryprogressiveaphasia
AT grossmanmurray validatedautomaticspeechbiomarkersinprimaryprogressiveaphasia